ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
12,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
13,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
14,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
14,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
16,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
17,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
17,3,Headache,Headaches NEC,Headaches,Nerv,N
17,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
17,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
18,1,Application site pustules,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
18,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
18,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
19,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
19,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
19,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
19,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
19,5,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
19,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
19,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
20,1,Bronchopulmonary dysplasia,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,Y
20,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
20,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
20,4,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
20,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
20,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
21,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
21,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
21,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
22,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
22,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
22,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
22,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
22,5,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
22,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
23,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
24,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
25,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
26,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
26,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
27,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
27,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
27,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,4,Tryptase increased,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
28,1,Application site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
28,2,Application site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
28,3,Application site haematoma,Application site reactions,Administration site reactions,Genrl,N
28,4,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
28,5,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
29,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
29,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
29,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
30,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
31,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
32,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
33,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
34,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
34,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
34,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
35,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
35,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
36,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
36,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
37,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
37,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
37,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
38,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
39,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
40,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
40,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
41,1,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
41,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
42,1,Allergy test positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
42,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
42,3,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
42,4,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
42,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
42,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
42,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
43,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
43,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
44,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
45,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
46,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
47,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
48,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
49,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
49,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
49,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
50,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
50,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
50,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
50,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
51,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
51,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
53,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
54,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
54,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
54,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
55,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
55,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
56,1,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
56,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
57,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
57,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
57,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
58,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
58,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
58,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
59,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
59,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
59,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
60,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
62,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
62,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
62,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
63,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
63,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
65,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
65,2,Rotator cuff syndrome,Joint related disorders NEC,Joint disorders,Musc,N
66,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
66,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
67,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
68,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
69,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
70,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
71,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
72,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
73,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
74,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
75,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
76,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
77,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
77,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
78,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
79,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
80,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
80,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
80,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
80,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
80,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
81,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
81,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
81,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
82,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
83,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
84,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
85,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
86,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
87,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
88,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
89,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
90,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
91,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
92,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
93,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
94,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
95,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
96,1,Genital discomfort,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
96,2,Scrotal swelling,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
97,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
97,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
98,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
98,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
99,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
99,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
99,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
100,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
101,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
102,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
102,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
102,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
103,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
104,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
105,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
105,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
105,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
105,4,Headache,Headaches NEC,Headaches,Nerv,N
105,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
105,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
106,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
106,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
107,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
107,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
107,3,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
108,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
108,2,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
109,1,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
110,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
111,1,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
112,1,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
113,1,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
114,1,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
115,1,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
116,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
117,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
118,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
119,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
119,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
119,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
120,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
121,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
122,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
123,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
125,1,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
126,1,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
127,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
127,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
128,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
129,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
130,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
130,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
130,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
131,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
131,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
131,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
131,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
132,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
133,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
134,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
135,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
135,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
135,3,Application site paraesthesia,Application site reactions,Administration site reactions,Genrl,N
135,4,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
136,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
137,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
137,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
137,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
138,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
138,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
138,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
139,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
139,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
139,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
140,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
140,2,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
140,3,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
140,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
141,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
141,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
142,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
142,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
142,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
143,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
143,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
143,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
143,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
143,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
144,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
145,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
145,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
146,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
147,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
147,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
149,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
150,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
151,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
152,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
152,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
152,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
153,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
153,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
154,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
154,3,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
155,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
155,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
155,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
156,2,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
156,3,Foreign body in eye,Eye injuries NEC,Injuries NEC,Inj&P,N
156,4,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
156,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,6,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
157,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
157,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
158,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
159,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
160,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
160,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
161,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
161,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
161,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
161,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
162,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
162,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
163,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
163,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
164,1,CSF shunt removal,Cerebrospinal fluid therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
164,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
165,1,CSF shunt removal,Cerebrospinal fluid therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
165,2,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
165,3,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
165,4,Wound decomposition,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
166,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
166,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
167,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
167,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
167,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
168,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
168,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
168,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
169,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
170,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
172,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
172,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
173,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
175,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
175,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
175,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
175,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
175,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
175,6,Superinfection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
176,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
176,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
176,3,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
176,4,Vessel puncture site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
177,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
178,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
179,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
179,2,Vessel puncture site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
180,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
180,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
181,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
182,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
182,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
182,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
182,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
183,1,Vessel puncture site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
184,1,Vessel puncture site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
185,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
185,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
186,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
186,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
187,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
188,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
188,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
188,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
189,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,1,Acinetobacter infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
190,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
191,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
192,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
193,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
193,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
193,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
195,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
196,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
197,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
197,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
198,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
198,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
199,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
200,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
201,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
202,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
203,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
204,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
205,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
206,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
207,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
207,2,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
207,3,Vessel puncture site inflammation,Administration site reactions NEC,Administration site reactions,Genrl,N
208,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
208,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
208,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
208,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
209,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
209,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
209,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
210,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
211,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
212,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
214,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
215,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
216,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
217,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
217,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
218,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
219,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
220,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
221,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
222,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
222,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
222,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
222,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
223,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
223,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
223,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
224,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
225,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
226,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
227,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
227,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
227,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
227,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
227,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
227,6,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
227,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
228,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
229,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
230,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
231,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
231,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
232,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
232,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
233,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
234,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
234,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
234,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
235,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
235,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
235,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
235,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
235,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
236,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
237,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
238,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
239,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
239,2,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
239,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
240,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
240,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
240,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
241,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
241,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
241,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
242,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
242,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
243,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
243,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
243,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
244,1,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
245,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
245,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
245,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
246,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
246,2,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
247,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
248,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
248,2,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
249,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
250,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
251,1,Catheter site erythema,Implant and catheter site reactions,Administration site reactions,Genrl,N
252,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
252,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
253,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
254,1,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
254,2,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
254,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
255,1,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
255,2,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
255,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
256,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
256,2,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
257,1,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
258,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
258,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
259,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
260,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
261,1,Administration site inflammation,Administration site reactions NEC,Administration site reactions,Genrl,N
262,1,Administration site inflammation,Administration site reactions NEC,Administration site reactions,Genrl,N
263,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
263,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
265,1,Administration site inflammation,Administration site reactions NEC,Administration site reactions,Genrl,N
266,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
266,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
266,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
267,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
268,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
269,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
270,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
270,2,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
271,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
272,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
272,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
272,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
272,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
272,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
272,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
273,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
274,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
275,1,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
276,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
277,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
278,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
279,1,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
279,2,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
280,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
281,1,Administration site inflammation,Administration site reactions NEC,Administration site reactions,Genrl,N
282,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
283,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
284,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
284,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
284,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
284,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
285,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
285,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
286,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
287,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
288,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
289,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
290,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
291,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
292,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
292,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
293,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
294,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
295,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
296,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
297,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
298,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
298,2,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
298,3,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
298,4,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
299,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
300,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
300,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
301,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
302,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
303,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
304,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
304,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
305,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
306,1,Catheter site discharge,Implant and catheter site reactions,Administration site reactions,Genrl,N
306,2,Catheter site erythema,Implant and catheter site reactions,Administration site reactions,Genrl,N
306,3,Catheter site haemorrhage,Implant and catheter site reactions,Administration site reactions,Genrl,N
306,4,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
306,5,Catheter site pruritus,Implant and catheter site reactions,Administration site reactions,Genrl,N
306,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
307,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
307,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
308,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
309,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
310,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
310,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
311,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
312,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
313,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
314,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
315,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
315,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
315,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
316,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
318,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
318,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
318,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
319,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
320,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
321,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
321,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
322,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
322,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
322,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
323,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
324,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
324,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
325,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
325,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
326,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
327,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
328,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
329,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
329,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
330,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
331,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
332,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
333,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
334,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
335,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
336,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
337,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
338,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
338,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
338,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
338,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
339,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
339,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
339,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
340,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
341,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
342,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
343,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
343,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
343,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
344,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
345,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
345,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
345,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
346,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
346,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
347,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
348,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
349,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
349,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
349,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
350,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
351,1,Catheter site rash,Implant and catheter site reactions,Administration site reactions,Genrl,N
351,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
351,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
352,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
352,2,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
353,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
354,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
355,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
356,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
356,2,Second degree chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
357,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
357,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
357,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
357,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
358,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
358,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
359,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
360,1,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
361,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
362,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
363,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
364,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
365,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
366,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
367,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
368,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
369,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
370,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
371,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
371,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
372,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
372,2,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
373,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
374,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
374,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
374,3,Repetitive strain injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
375,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
376,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
377,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
378,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
379,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
380,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
381,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
382,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
383,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
384,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
384,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
384,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
385,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
